Tech Company M&A Transactions

NovaCardia Acquisition

NovaCardia was bought by Merck. The transaction occurred on 7/25/2007. Merck said the transaction price was $350 million.

Transaction Overview

Company Name
Acquired By
Announced On
7/25/2007
Transaction Type
M&A
Amount
$350,000,000
M&A Terms
The acquisition will be paid for with all stock.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12651 High Bluff Drive 200
San Diego, CA 92130
USA
Email Address
Not Recorded
Overview
NovaCardia is a product-focused pharmaceutical company with significant capabilities and experience in cardiovascular drug development.
Profile
NovaCardia LinkedIn Company Profile
Social Media
NovaCardia Company Twitter Account
Company News
NovaCardia News
Facebook
NovaCardia on Facebook
YouTube
NovaCardia on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Randall Woods
  Randall Woods LinkedIn Profile  Randall Woods Twitter Account  Randall Woods News  Randall Woods on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/25/2007: Cyntellect venture capital transaction
Next: 7/25/2007: Navotek Medical venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary